Product Details for: Susvimo

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravitreal
100MG/ML
Single-Dose Vial
351(a)
Susvimo
Rx
Proper Name
ranibizumab
BLA Number
761197
Applicant
Genentech, Inc.
Original Approval Date
October 22, 2021
Date of First Licensure
RETURN TO SEARCH RESULTS